Amylyx Pharmaceuticals

Price & Volume

Stats

52W Range	$2.60-$16.96
Market Cap	$1.6B
Shares Short	10M

Financials

Revenue (12 Mos)	-$665,000
Revenue Growth (YoY)	-99.6%
Gross Profit (12 Mos)	-$56.5M
Diluted EPS	-$1.79

News

Yahoo Finance • 17 days ago

December 2026 Options Now Available For Amylyx Pharmaceuticals (AMLX)

Yahoo Finance • 18 days ago

Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf

Yahoo Finance • 25 days ago

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf

Yahoo Finance • last month

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM): Grabar Law Office is Investigating Claims on Your Behalf

About

CEO	Mr. Joshua B. Cohen
Address	43 Thorndike Street, Cambridge, MA, United States, 02141
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	123